genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
Coronavirus
Pfizer, BioNTech Publish “Encouraging” Interim Phase I/II Data for COVID-19 Vaccine…
Cancer
Microbiome Signature Could Predict Cirrhosis Noninvasively
Drug Discovery
MRSA Vaccine that Targets Toxic Molecules Protects Mice from Deadly Infection
Insights
All
Trends for 2020
Bioprocessing
Bioprocess 4.0 Approach Will Help Biopharma Achieve Regulators’ Goals
Bioprocessing
Digitalized Twin Model of the Workhorse
Bioprocessing
Mitigating Viral Contamination, a Challenge for Emerging Therapies
CAR T-Cells
Nonviral Genetic Engineering of CAR T Cells
A-Lists
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
eBooks
IsoPlexis’ Unique, Predictive Biology
Coronavirus
Pfizer, BioNTech Publish “Encouraging” Interim Phase I/II Data for COVID-19 Vaccine…
Magazine
All
Special Report
June 2020 Vol. 40 No. 6
The Human Genome Project in 2020 Hindsight
Commentary
3D Microscopy Keeps Getting Faster, Smarter, Leaner
Roundtable
Perspectives on Microscopy
Bioprocessing
Biomanufacturers Cope with Challenges of Going Continuous
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
IsoPlexis’ Unique, Predictive Biology
eBooks
Engineering the Immune Response for Therapeutic Success
Upcoming Webinars
Packaging and Producer Cell Lines for Scalable Lentiviral Production
CRISPR-Cas9
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Biogen
Biogen
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biogen
Biogen, Vir to Partner on Manufacturing Antibodies to Treat COVID-19
Biogen
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
Biogen
Fujifilm Diosynth to Expand with $890M Purchase of Biogen’s Danish Biologics Manufacturing Site
Biogen
Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar Acquisition
Biogen
“Some Hope”: Biogen, Eisai Release Positive Phase II Results for Alzheimer’s Candidate
Biogen
Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal
Biogen
Biogen Buys Option to TMS’ Phase II Stroke Candidate
Biogen
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
Biogen
Biogen Buys Pfizer Neuropsychiatry Candidate for Up-to-$590M+
Biogen
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Biogen
Biogen Halts Development of Tysabri for Acute Ischemic Stroke after Phase...
Biogen
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Biogen
Biogen to Develop Alkermes’ MS Candidate ALKS 8700
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
